A groundbreaking clinical trial has demonstrated that a meticulously designed combination of a low-calorie diet and supervised exercise can lead to remission of type 2 diabetes in over half of younger adults within a mere six months. This intensive lifestyle program achieved significantly higher remission rates compared to standard medical care, offering a beacon of hope for a growing demographic facing this chronic condition. The findings, presented at the prestigious Annual Meeting of the European Association for the Study of Diabetes (EASD) and simultaneously published in the esteemed journal The Lancet Regional Health Americas, suggest a transformative approach to managing early-onset type 2 diabetes (EOT2D), defined as diagnosis in individuals under the age of 45.
The Urgency of Early-Onset Type 2 Diabetes
The implications of type 2 diabetes developing at a younger age are particularly concerning. Individuals diagnosed with EOT2D often experience a more aggressive disease trajectory. This can manifest as a faster deterioration of blood glucose control, an earlier onset of debilitating complications such as cardiovascular disease, kidney damage, and nerve damage, and ultimately, a reduced life expectancy. The metabolic demands and lifestyle factors associated with youth, coupled with potential genetic predispositions, may contribute to this accelerated progression. Therefore, interventions that can effectively halt or reverse the disease process in its early stages are critically needed.
Pioneering Research and the RESET for Remission Study
The research, a collaborative effort led by Professor Kaberi Dasgupta, Director of the Division of General Internal Medicine at McGill University in Montreal, Canada, and Professor Thomas Yates of the University of Leicester in the UK, along with their international colleagues, sought to build upon existing knowledge regarding very low-calorie diets (VLCDs) and their impact on type 2 diabetes. Previous studies had indicated that VLCDs could lead to significant weight loss and, in some cases, diabetes remission without the need for medication. Remission is defined as achieving blood glucose levels below the diagnostic threshold for diabetes and maintaining them without the use of glucose-lowering drugs. However, it is crucial to note that remission does not equate to a permanent cure, and ongoing vigilance is necessary.
This new study, aptly named "RESET for Remission," aimed to investigate whether augmenting VLCDs with a structured exercise regimen could enhance the efficacy of remission rates. The rationale behind incorporating exercise is multifaceted. Beyond its well-established role in blood sugar regulation, physical activity can bolster overall fitness, play a crucial role in preserving lean muscle mass during weight loss – a common challenge with calorie restriction alone – improve cardiovascular function, and enhance insulin sensitivity. The researchers hypothesized that this dual approach would not only accelerate remission but also contribute to broader health improvements.
The Design of an Intensive Lifestyle Intervention
The randomized clinical trial adopted a rigorous design to compare the intensive lifestyle intervention against standard care. Enrolling adults aged 18 to 45 who had been diagnosed with early-onset type 2 diabetes and were also managing obesity but were not yet on insulin therapy, the study was conducted across three research centers in England and Canada, affiliated with the University of Leicester, McGill University, and the University of Alberta. The trial was open-label, meaning both participants and researchers were aware of the treatment allocation. However, the primary outcome assessment was conducted in a blinded manner to ensure objectivity.
Participants were randomly assigned to one of two groups. The control group continued to receive their usual medical care, which typically involves medication, dietary advice, and regular check-ups. The intervention group, however, embarked on an intensive program designed to induce rapid weight loss and metabolic change. This program involved a daily caloric intake restricted to 800 to 900 calories, coupled with a structured exercise regimen. This regimen included supervised aerobic and resistance training sessions twice per week, supplemented by one independent exercise session each week for the initial 12 weeks. Following this intensive phase, participants transitioned to a maintenance phase (weeks 13-24), focusing on sustaining their weight loss through a modified diet and continued independent exercise.
The primary endpoint of the study was the achievement of diabetes remission at 24 weeks. To qualify for remission, participants were required to have an HbA1c level below 6.5% (equivalent to 48 mmol/mol) and to have been off all glucose-lowering medications for at least 12 weeks. HbA1c is a critical diagnostic tool that provides an average measure of blood sugar levels over the preceding two to three months. The researchers meticulously analyzed data from all randomized participants, employing a conservative approach by counting any participants with missing remission data as not having achieved remission. Furthermore, the study extended its assessment to include changes in cardiovascular fitness, body composition, and heart structure, providing a holistic view of the intervention’s impact.
Nutritional Framework: A Phased Approach to Calorie Restriction
The dietary component of the intensive intervention was carefully structured to ensure nutritional adequacy while facilitating significant weight loss. At the outset, participants discontinued their diabetes and blood pressure medications under strict medical supervision, provided there were no signs of albuminuria, an indicator of potential kidney damage. The restricted diet provided 800 to 900 calories daily, with a macronutrient distribution of 30% protein, 50% carbohydrate, and 20% fat. Participants were advised to consume at least two liters of calorie-free fluids daily and were provided with fiber-based laxatives as needed to manage potential digestive discomfort.
The initial two weeks of the program involved a complete meal replacement using specially formulated nutritional products (Optifast in the UK and ProtiDiet in Canada). This approach ensures precise calorie and nutrient delivery during the critical initial phase of rapid weight loss. From weeks three to 12, participants continued with the 800-900 calorie limit but were granted more flexibility in their food choices, incorporating one conventional meal per day alongside the nutritional products. This conventional meal was designed to meet daily targets for protein (60-90g from all sources), one portion of fruit, and two portions of non-starchy vegetables, promoting the consumption of whole foods while maintaining calorie control.
After the initial 12-week intensive phase, the focus shifted from rapid weight reduction to weight maintenance. Participants continued their exercise regimen independently, and their dietary intake was adjusted to support their new lower body weight, preventing the regain of lost pounds.
Striking Remission Rates and Significant Weight Loss
The RESET for Remission trial enrolled and randomized a total of 96 participants between September 24, 2021, and June 6, 2025. The cohort comprised 40 participants from the UK and 56 from Canada. Of these, 50 were assigned to the intensive intervention group and 46 to the standard care group. The demographic breakdown included 24 females and 26 males in the intervention group, and 21 females and 25 males in the control group. The mean age of participants was 38 years, with an average Body Mass Index (BMI) of 35.2 kg/m², indicating obesity in both groups. A high retention rate was observed, with 86% (90%) of participants completing the final assessments.
The results unveiled a dramatic disparity between the two groups. After 24 weeks, an impressive 27 out of the 50 participants in the intensive diet and exercise program achieved diabetes remission, translating to 54% of the intervention group. In stark contrast, only two participants out of the 46 in the standard care group reached remission, representing approximately 4%.
Statistical analysis, which accounted for relevant confounding factors, revealed that participants in the intensive lifestyle program were an astonishing 21 times more likely to achieve diabetes remission compared to those receiving usual care. This remarkable difference underscores the potent impact of the structured lifestyle intervention.
Beyond remission, the intervention group also experienced substantially greater weight loss. Among the 47 intervention participants with available weight data, their average body weight decreased from 100.7 kg to 92.3 kg, a reduction of 8.4 kg over the 24-week period. The 43 control participants with weight data saw a more modest loss of only 1.2 kg, moving from an average of 103.2 kg to 102.0 kg. After statistical adjustment, the intervention group exhibited an average weight loss of 7.5 kg more than the control group. Crucially, this difference was largely attributed to a greater loss of body fat, with the intervention group shedding an additional 6.6 kg of fat mass. This finding is particularly significant, as it indicates that the weight loss achieved through the intervention was primarily composed of fat, rather than essential lean body mass.
Manageable Side Effects and Holistic Health Benefits
While the intensive diet led to a higher incidence of adverse events compared to standard care, these effects were generally mild and transient. Among the 50 participants in the intervention group, 43 experienced at least one adverse event, primarily during the initial stages of the restrictive diet. These included common side effects such as constipation, headaches, dizziness, and fatigue. These symptoms typically resolved as participants adapted to the dietary changes. No severe adverse events were reported throughout the trial, suggesting that the intervention, when medically supervised, is safe for this population.
The researchers emphasized that the benefits of the intervention extended far beyond mere blood sugar control. The study’s findings demonstrate the feasibility and efficacy of integrating structured aerobic and resistance exercise with a low-energy diet in individuals with early-onset type 2 diabetes. This combined approach holds the potential to deliver substantial and holistic health and well-being benefits, alongside the achievement of diabetes remission. The authors highlighted that their remission rates are among the highest reported in similar duration trials, reinforcing the power of structured lifestyle interventions. Notably, this study is among the first to demonstrate such significant effects in a multi-ethnic population with early-onset type 2 diabetes.
The Critical Role of Muscle Preservation
A key innovation and focus of the RESET for Remission study was its deliberate emphasis on preserving muscle mass during the period of rapid weight loss. The researchers acknowledge that a common challenge in weight loss programs, particularly those employing very low-calorie diets, is the loss of lean body mass, which includes muscle. This can occur because calorie restriction alone often leads to a reduction in both fat and fat-free mass. Evidence suggests that when weight is regained, the body may preferentially regain fat over lean tissue, potentially leading to a gradual decline in muscle mass over time and an increased risk of sarcopenia – the age-related loss of muscle mass and strength.
To counteract this, the RESET for Remission study integrated resistance training into the most intensive phase of weight loss. The results of the study provide compelling evidence that it is indeed possible to achieve substantial fat loss while effectively preserving muscle mass. This preservation of lean body mass is crucial for long-term metabolic health, physical function, and potentially, for sustaining diabetes remission. The researchers suggest that this aspect of the intervention may have significant implications for the long-term health trajectory of individuals with type 2 diabetes, an area that warrants further long-term investigation.
A Paradigm Shift in Type 2 Diabetes Management?
The findings of the RESET for Remission study arrive at a critical juncture, as the prevalence of type 2 diabetes continues to surge among younger adults globally. For individuals diagnosed early in life, the extended exposure to elevated blood glucose levels translates to a significantly increased lifetime risk of developing serious cardiovascular disease and other debilitating complications. Therefore, achieving remission early in the disease course holds immense potential for improving long-term health outcomes and reducing the burden of diabetes-related morbidity and mortality.
The intervention’s impact was not confined to metabolic markers. It demonstrably reduced body fat while safeguarding muscle, improved muscle quality and physical performance, bolstered cardiovascular health, and led to significant improvements in participants’ self-reported well-being. The researchers also noted the potential relevance of this strategy for individuals planning or who may become pregnant, as optimized metabolic health can be crucial for maternal and fetal well-being.
However, the researchers prudently cautioned that longer-term studies are essential to ascertain the sustainability of these benefits. Future research must focus on how well participants maintain their weight loss, muscle mass, and diabetes remission once they transition back to their everyday lives outside the closely monitored clinical trial setting.
Looking Ahead: Re-evaluating Treatment Paradigms
In their concluding remarks, the authors of the RESET for Remission study highlighted the growing clinical significance of early-onset type 2 diabetes, characterized by elevated cardiovascular disease risk, a greater cumulative burden of complications, and generally poorer long-term outcomes. Their research provides compelling evidence that combining structured aerobic and resistance exercise with a low-calorie diet in this specific population can yield high remission rates, induce significant fat loss while preserving muscle mass, enhance muscle quality and function, improve cardiovascular health, and lead to meaningful improvements in patient-reported outcomes.
As the global prevalence of early-onset type 2 diabetes continues to rise, these findings present a compelling opportunity to re-evaluate current treatment paradigms. The study advocates for the support of scalable implementation of integrated dietary and exercise interventions aimed at achieving diabetes remission. The researchers believe their approach may be particularly valuable for individuals seeking or who have the potential for pregnancy, and they strongly recommend further evaluation in longer-term studies conducted in real-world settings. This promising research opens a new chapter in the fight against type 2 diabetes, offering a powerful, evidence-based strategy for achieving remission and improving the long-term health of younger adults.
